Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma

por Gemmill, R M, Zhou, M, Costa, L, Korch, C, Bukowski, R M, Drabkin, H A
Publicado 2005

Integrating text mining into the MGI biocuration workflow

por Dowell, K.G., McAndrews-Hill, M.S., Hill, D.P., Drabkin, H.J., Blake, J.A.
Publicado 2009

Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas

por Ueda, M, Gemmill, R M, West, J, Winn, R, Sugita, M, Tanaka, N, Ueki, M, Drabkin, H A
Publicado 2001

Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib

por Flaig, T W, Costa, L J, Gustafson, D L, Breaker, K, Schultz, M K, Crighton, F, Kim, F J, Drabkin, H
Publicado 2010